Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer

Figure 3

Levels of resistin and EGFR expression were associated with survival of patients with breast cancer. Associations were analyzed between resistin-positive expression and (a) relapse-free survival (RFS) and also (b) overall survival (OS). Associations were analyzed between strongly positive resistin expression and (c) RFS and also (d) OS. Associations were analyzed between strongly positive and weakly-positive resistin expression and (e) RFS and also (f) OS. Associations were analyzed between EGFR-positive expression and (g) RFS and also (h) OS. Associations were analyzed between strongly positive EGFR expression and (i) RFS and also (j) OS. Kaplan-Meier curves for (k) RFS and (l) OS in breast cancer patients with combined resistin-positive and EGFR-positive expression. Kaplan-Meier curves for (m) RFS and (n) OS in breast cancer patients with combined resistin-positive and strongly positive EGFR expression. Kaplan-Meier curves for (o) RFS and (p) OS in breast cancer patients with combined strongly positive resistin and EGFR-positive expression. Kaplan-Meier curves for (q) RFS and (r) OS in breast cancer patients with combined strongly positive resistin and strongly positive EGFR expression. values were calculated using the Mantel-Cox log-rank test.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)